During the past decade, USF Parkinson's Disease and Movement Disorders Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "USF Parkinson's Disease and Movement Disorders Center" #1 sponsor was "Sunovion" with 3 trials, followed by "Enterin Inc." with 2 trials sponsored, "Ipsen" with 2 trials sponsored, "Revance Therapeutics, Inc." with 2 trials sponsored and "Cerevance Beta, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "USF Parkinson's Disease and Movement Disorders Center" #1 collaborator was "Syneos Health" with 2 trials as a collaborator, "Prothena Biosciences Limited" with 1 trials as a collaborator and "Wellness Health & Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "USF Parkinson's Disease and Movement Disorders Center" are "Parkinson's Disease" (8 trials), "Parkinson Disease" (5 trials), "Cervical Dystonia" (4 trials), "Constipation" (2 trials) and "Essential Tremor" (1 trials). Many other conditions were trialed in "USF Parkinson's Disease and Movement Disorders Center" in a lesser frequency.

Most popular intervention types in "USF Parkinson's Disease and Movement Disorders Center" are "Drug" (14 trials), "Biological" (3 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "APL-130277" (3 trials), "0.9% sodium chloride (normal saline)" (1 trials), "Active Investigational Treatment ENT-01" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "USF Parkinson's Disease and Movement Disorders Center" are 19 trials for "All" genders.

Currently, there are NaN active trials in "USF Parkinson's Disease and Movement Disorders Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in USF Parkinson's Disease and Movement Disorders Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in USF Parkinson's Disease and Movement Disorders Center, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".